Skip to main content
Log in

Accumulation of heparan sulfate in the culture of human melanoma cells with different metastatic ability

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Glycosaminoglycans were metabolically labeled in subconfluent cultures of highly metastatic 7Gp122 and poorly metastatic IC8 variants and of the low metastatic parental M4Be human melanoma cell line. Proteoglycans were separated by DEAE Trisacryl chromatography from the culture medium, from the heparin extract of the cell layer and from the heparin-extracted cell residue lyzed with detergents. Glycosaminoglycans were released from the proteoglycans by reductive alkaline hydrolysis and heparan sulfate (HS) was detected by deaminative cleavage with nitrous acid. Expressed on cell protein basis, the labeled HS content in the medium and in the cell layer decreased with increasing metastatic ability. The extraction of HS with heparin from the 7Gp122 cells indicated that this variant was enriched in (polypeptide bound) HS non inserted into the plasma membrane, compared with the low metastatic IC8 and M4Be cells. The HS fraction in heparin extract and in the heparin-extracted cell residue exhibited molecular mass heterogeneity on gel permeation chromatography and it contained HS fragments. Scission with nitrous acid followed by molecular sieve chromatography of the degradation products indicated that the tetra- and disaccharide repeats separated by the N-sulfated glucosamine residues were present in about equal amounts and constituted 60% of the HS chains in the IC8 and M4Be cells. HS from 7Gp122, IC8 and M4Be cells did not bind antithrombin III with high affinity but it was capable of binding bFGF in in vitro assay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gallagher JT, Lyon M and Steward WP, 1986, Structure and function of heparan sulphate proteoglycans. Biochemical Journal, 236, 313–325.

    Google Scholar 

  2. Kjellén KL and Lindahl U, 1991, Proteoglycans: structures and interactions. Annual Review of Biochemistry, 60, 443–475.

    Google Scholar 

  3. Lindahl U and Kjellen L, 1987, Biosynthesis of heparin and heparan sulfate. In: Wight TN and Mecham RP eds. Biology of Proteoglycans. Orlando: Academic Press, pp. 59–104

    Google Scholar 

  4. Ruoslahti E, 1988, Structure and biology of proteoglycans. Annual Review of Cell Biology, 4, 229–255.

    Google Scholar 

  5. Fransson A and Havsmark B, 1982, Copolymeric glycosaminoglycans in transformed cells. Biochemical Journal; 201, 233–240.

    Google Scholar 

  6. Keller KL, Keller JM and Moy JN, 1980, Heparan sulfates from swiss mouse 3T3 and SV 3T3 cells: O-sulfate difference, Biochemistry, 19, 2529–2536.

    Google Scholar 

  7. Winterbourne DJ and Moora PT, 1981, Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with re duced degree of sulfation. Journal of Biological Chemistry, 256, 4310–4320.

    Google Scholar 

  8. Iozzo RV and Wight TN, 1982, Isolation anc characterization of proteoglycans synthesized b3 human colon and colon carcinoma. Journal of Biological Chemistry, 257, 11135–11144.

    Google Scholar 

  9. Jalkanen M, Elenius K, Inki P, Kirjavainen J and Leppä S, 1991, Syndecan, a regulator of cell behaviour, is lost in malignant transformation. Biochemical Society Transactions, 19, 1069–1072.

    Google Scholar 

  10. Redini R, Moczar E and Poupon MF, 1986, Cell surface glycosaminoglycans of rat rhabdomyosarcoma cell lines with different metastatic potentials and of non malignant myoblasts. Biochimica et Biophysica Acta, 883, 98–105.

    Google Scholar 

  11. Kure S, Yoshie O and Aso H, 1987, Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan. Japanese Journal of Cancer Research, 78, 1238–1245.

    Google Scholar 

  12. Kramer RH and Vogel KG, 1984, Selective degradation of basement membrane molecules by metastatic melanoma cells. Journal of the National Cancer Institute, 72, 889–897.

    Google Scholar 

  13. Vlodavski I, Ariav Y, Atzmon R and Fuks Z, 1982, Tumor cell attachment to vascular endothelium and subsequent degradation of subendothelial extracellular matrix. Experimental Cell Research, 140, 149–159.

    Google Scholar 

  14. Redini F, Moczar E, Antoine E and Poupon MF, 1989, Binding and internalisation of exogenous glycosaminoglycans in weakly and highly metastatic rhabdomyosarcoma cells. Biochimica et Biophysica Acta, 991, 359–366.

    Google Scholar 

  15. Timar J, Moczar M, Lapis K and Moczar E, 1990, Interactions of exogenous heparan sulfate with tumor cells of different metastatic phenotype. Invasion and Metastasis, 10, 301–305.

    Google Scholar 

  16. Nakajima M, Irimura T, Diferrante N and Nicolson GI, 1984, Metastatic melanoma cell heparanase. Journal of Biological Chemistry, 259, 2283–2290.

    Google Scholar 

  17. Nakajima M, Irimura T and Nicolson GL, 1988, Heparanases and tumor metastasis. Journal of Cell Biochemistry, 36, 157–167.

    Google Scholar 

  18. Ricoveri W and Cappelletti R, 1986, Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma. Cancer Research, 48, 3855–3861.

    Google Scholar 

  19. Bumol TF, Walker L and Reisfeld RA, 1984, Biosynthetic studies of proteoglycans in human melanoma cells with monoclonal antibody to a core protein glycoprotein of chondroitin sulfate proteoglycans. Journal of Biological Chemistry, 259, 12733–12741.

    Google Scholar 

  20. Harper JR, Quarante V and Reisfeld RA, 1986, Ammonium chloride interferes with a distinct step in the biosynthesis and cell surface expression of human melanoma type chondroitin sulfate. Journal of Biological Chemistry, 261, 3600–3606.

    Google Scholar 

  21. Harper JR and Reisfeld RA, 1987, Cell associated proteoglycans in human malignant melanoma. In: Wight TN and Mecham RP eds. Biology of Proteoglycans. Orlando: Academic Press, pp. 345–365.

    Google Scholar 

  22. Roberts DD, 1988, Interactions of thrombospondin with sulfated glycolipids and proteoglycans of human melanoma cells. Cancer Research, 48, 6785–6793.

    Google Scholar 

  23. Caux F, Timar J, Vigny M and Moczar M, 1992, Heparan sulfate synthesized by human melanoma cell variants. The Cancer Journal, 5, 111–117.

    Google Scholar 

  24. Bailly M and Dore JF, 1991, Human tumor spontaneous metastasis in immunosuppressed newborn rats. II. Multiple selections of human melanoma meta static clones and variants. International Journal of Cancer, 49, 750–757.

    Google Scholar 

  25. Bailly M, Bertrand S and Dore JF, 1989, Experimental model of human tumor spontaneous metastasis in immunosuppressed newborn rat. In: Wu B and Zheng J eds. Immuno-deficient Animals in Experimental Medicine. Basel: Karger, pp. 140–146.

    Google Scholar 

  26. Bailly M, Bertrand S and Dore JF, 1991, Human tumor spontaneous metastasis in immunosuppressed newborn rats. I. Characterization of the bioassay. International Journal of Cancer, 49, 457–466.

    Google Scholar 

  27. Kjellén KL, Oldberg A and Höök M, 1980, Cell surface heparan sulfate. Mechanisms of proteoglycan association. Journal of Biological Chemistry, 255, 10407–10413.

    Google Scholar 

  28. Turnbull JE and Gallagher JT, 1990, Molecular organization of heparan sulphate from human skin fibroblasts. Biochemical Journal, 265, 715–724.

    Google Scholar 

  29. Woods A, Couchman JR and Höök M, 1985, Heparan sulfate proteoglycans of rat embryo fibroblasts. Journal of Biological Chemistry, 260, 10872–10979.

    Google Scholar 

  30. Hassel RJ, Robey PG, Barrach H, Wilczek JR, Rennard S and Martin G, 1980, Isolation of heparan sulfate containing proteoglycans from a mouse tumor basement membrane. Proceedings of the National Academy of Science, USA, 77, 4494–4498.

    Google Scholar 

  31. Saito HS, Yamagata T and Suzuki S, 1968, Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. Journal of Biological Chemistry, 243, 1536–1542.

    Google Scholar 

  32. Gamse G, Fromme HS and Kresse H, 1978, Metabolism of sulfated glycosaminoglycans in cultured endothelial cells and smooth muscle cells from bovine aorta. Biochimica et Biophysica Acta, 544, 514–528.

    Google Scholar 

  33. Hovingh P, Piepkorn M and Linker A, 1986, Biological implications of the structural antithrombin affinity and anticoagulant relationships among vertebrate heparins and heparan sulphates. Biochemical Journal, 237, 573–581.

    Google Scholar 

  34. Linhardt RJ, Turnbull JE, Wang HM, Loganathan D and Gallagher JT, 1990, Examination of substrate specificity of heparin and heparan sulfate lyases. Biochemistry, 29, 2611–2617.

    Google Scholar 

  35. Jacobsson KG, Lindahl U and Horner AA, 1986, Location of antithrombin-binding regions in rat skin heparin proteoglycans. Biochemical Journal, 240, 625–632.

    Google Scholar 

  36. Ishihara MY, Fedarko NS and Conrad HE, 1987, Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulfate metabolism and hepatocyte growth. Journal of Biological Chemistry, 262, 4708–4716.

    Google Scholar 

  37. Yanagashita M and McQuillan DJ, 1989, Two forms of plasma membrane intercalated heparan sulfate proteoglycan in rat ovarian granulosa cells. Journal of Biological Chemistry, 264, 17551–17558.

    Google Scholar 

  38. Jalkanen M, Rapraeger A, Saunders S and Bernfield M, 1987, Cell surface proteoglycan of mouse mammary epithelia cells is shed by cleavage of its membrane associated domain. Journal of Cell Biology, 105, 3087–3095.

    Google Scholar 

  39. Mali M, Jaakkola P, Arvilomni AM and Jalkanen M, 1990, Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. Journal of Biological Chemistry, 265, 6884–6889.

    Google Scholar 

  40. Bienkowski MJ and Conrad HE, 1984, Kinetics of proteoheparan sulfate synthesis, secretion, endocytosis and catabolism by a hepatocyte cell line. Journal of Biological Chemistry, 259, 12989–12996.

    Google Scholar 

  41. Sjöberg I, Carlstedt I, Caster L, Malmström A and Fransson LA, 1979, Structure and metabolism of sulphated glycosaminoglycans in cultures of human fibroblasts. Biochemical Journal, 178, 157–270.

    Google Scholar 

  42. Kjellen L, Pertoft H, Oldberg A and Höök M, 1985, Oligosaccharides generated by an endoglucuronidase are intermediates in the intracellular degradation of heparan sulfate proteoglycan. Journal of Biological Chemistry, 260, 8416–8422.

    Google Scholar 

  43. Lindahl U, Thunberg L, Bäckström G, Riesenfeld J, Nordling K and Björk I, 1984, Extension and structural variability of the antithrombin-binding sequence in heparin. Journal of Biological Chemistry, 259, 12368–12376.

    Google Scholar 

  44. Burgess WH and Maciag T, 1989, The heparinbinding (fibroblast) growth factor family of proteins. Annual Review of Biochemistry, 58, 575–606.

    Google Scholar 

  45. Turnbull JE, Fernig DG, Ke Y, Wilkinson MC and Gallagher JT, 1992, Identification of basic fibroblasts growth factor binding sequence in fibroblasts heparan sulfate. Journal of Biological Chemistry, 267, 10337–10341.

    Google Scholar 

  46. Habushi H, Suzuki S, Saito T, Tamura T, Harada T, Yoshida K and Kimata K, 1992, Structure of heparan sulphate oligosaccharide that binds to basic fibroblast growth factor. Biochemical Journal, 285, 805–813.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moczar, M., Caux, F., Bailly, M. et al. Accumulation of heparan sulfate in the culture of human melanoma cells with different metastatic ability. Clin Exp Metast 11, 462–471 (1993). https://doi.org/10.1007/BF00054937

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00054937

Keywords

Navigation